Thyroid Hormones and Derivatives Inhibit Flunitrazepam Binding

A. Nagy, A. Lajtha

Research output: Contribution to journalArticleResearchpeer-review

27 Citations (Scopus)

Abstract

Abstract: Thyroid hormones and their derivatives were found to inhibit [3H]flunitrazepam binding stereospe‐cifically and in a monophasic manner. Among the compounds tested, D‐thyroxine was the most potent inhibitor (IC50= 0.5 μM). The naturally occurring L‐thyroxine was about 40‐fold less potent (IC50= 20 μM). The structure‐activity relationships seem to imply that the thyronine base has the principal role in the inhibition of benzo‐diazepine receptor binding. The type of inhibition was examined with the most potent inhibitor, D‐thyroxine, by Scatchard analysis. The apparent dissociation constant (KD) of the [3H]flunitrazepam binding increased and the receptor density (Bmax) decreased as a function of D‐thyroxine concentration; this is characteristic of mixed‐type inhibition.

Original languageEnglish
Pages (from-to)414-417
Number of pages4
JournalJournal of Neurochemistry
Volume40
Issue number2
DOIs
Publication statusPublished - 1983
Externally publishedYes

Keywords

  • Benzodiazepine receptors
  • Thyroid hormones
  • Thyronine‐Mixed‐type inhibition

Cite this